The Grand Winner
July 6, 2026
IMA Active’s DOMINA has been voted the Grand Winner of The Medicine Maker Innovation Awards 2025
6 min read
False
Advertisement
Small Molecules
Reformulating the Future of Small Molecules
June 30, 2026
A special collection of recent stories exploring oral dose innovation, API stability, nitrosamine testing, and the evolving science of small molecule medicines
1 min read
Rewriting the Neuroscience Playbook
By James Strachan
June 23, 2026
Merz Therapeutics is exploring botulinum toxin in chronic pain – a test case for unconventional thinking in neuroscience drug development
4 min read
The Case for Simulating Pregnancy
By Jessica Allerton
June 2, 2026
Why drug trials exclude pregnant women – and how simulation could change that
7 min read
Pharma Supply Chains in the Crossfire
May 5, 2026
How tariff uncertainty and geopolitical tensions are reshaping pharmaceutical logistics
6 min read
What Sponsors Get Wrong When Initiating an Oncology Study
By Luke Gill, Claudio Hegenberger
May 4, 2026
How CRO selection significantly influences study outcomes
6 min read
Trends and Challenges in Nitrosamine Testing: Part Five – Pharma’s Future
May 1, 2026
Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry
3 min read
Trends and Challenges in Nitrosamine Testing: Part Three – Building a Method
April 24, 2026
Following part two, which explored the analytical challenges involved in nitrosamine testing, our experts return to offer their top tips for building a method from scratch
4 min read
The Secrets of the Gut
April 20, 2026
Going beyond the gut: why microbiome testing is the next big thing in drug development
3 min read
Trends and Challenges in Nitrosamine Testing Part Four The Regulatory Landscape
April 17, 2026
Following part two, which explored the analytical challenges involved in nitrosamine testing, our experts return to offer their top tips for building a method from scratch
2 min read
